Chr. Boasquevisque et al., Liposome-mediated gene transfer in rat lung transplantation: A comparison between the in vivo and ex vivo approaches, J THOR SURG, 117(1), 1999, pp. 8-14
Citations number
11
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: We compared the efficacy of in vivo and ex vivo liposome transfe
ction in rat lung transplantation, Methods: (1) Chloramphenicol acetyltrans
ferase group: Fischer rats underwent isogeneic transplantation (n = 4 per g
roup). Recipients were put to death on postoperative day 2 for chlorampheni
col acetyltransferase activity Ex vivo setting: Grafts received cDNA comple
xed or not with liposomes and were transplanted after 1.5 or 10 hours at 10
degrees C. In vivo setting: Donors were intravenously injected with cDNA c
omplexed or not with liposomes, Lungs were harvested after 1.5 or 10 hours,
preserved at 10 degrees C, and transplanted, (2) Transforming growth facto
r-beta 1 group: Brown-Norway rats served as donors and Fischer rats as reci
pients. All grafts were preserved for 3 hours at 10 degrees C. On postopera
tive day 5, arterial oxygenation and histologic rejection scores were asses
sed. Ex vivo setting: Grafts received transforming growth factor-beta 1 sen
se (n = 8) or antisense (n = 7) complexed with liposomes or cDNA alone (n =
5), In who setting: Donors were intravenously injected with liposome:trans
forming growth factor-beta 1 sense cDNA (n = 7), Exposure time was 3 hours.
Results: (1) Chloramphenicol acetyltransferase-transfection was superior i
n the ex vivo group but was not statistically different for longer exposure
times. (2) Transforming growth factor-beta 1-arterial oxygenation was supe
rior in the ex vivo liposome:sense group. cDNA alone was inefficient. Rejec
tion scores were not statistically different between ex vivo and in vivo li
posome:sense groups but were better when the ex vivo liposome:sense group w
as compared with the cDNA alone or the antisense groups. Conclusions: (1) W
ith current liposome technology, the ex vivo route is superior to the in vi
vo approach; (2) cDNA alone does not provide transgene expression at levels
to produce a functional effect.